EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Laboratory approaches in desensitization for ABO-incompatible transplantation

Kyung-Hwa Shin iD, Hyun-Ji Lee iD

Clinical Transplantation and Research · 2025-09-30 · 39 (3) · 250-258

DOI: 10.4285/ctr.25.0041 ↗

At a glance

Übersichtsarbeit in Clinical Transplantation and Research, published online on 2025-09-05. Written by Kyung-Hwa Shin and 1 co-authors. Institution: Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, Korea. Cited 4 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

ABO-incompatible transplantation, once considered contraindicated due to the risk of hyperacute rejection, has become a viable option owing to advances in immunosuppression and desensitization methods. Accurate measurement and effective reduction of anti-ABO isoagglutinin titers are essential for the success of ABO-incompatible transplantation. This review summarizes the principles of hemagglutination and the measurement of isoagglutinin titers, highlighting variables that influence agglutination sensitivity. The clinical significance of isoagglutinin rebound and its association with rejection risk are also discussed, along with ongoing efforts toward laboratory standardization. Antibody-mediated rejection (AMR) is strongly linked to high pretransplant isoagglutinin titers (≥1:32). Posttransplant isoagglutinin rebound-an important risk factor for AMR-requires careful monitoring in liver and kidney transplant recipients with high initial titers. Desensitization strategies include rituximab, plasmapheresis, intravenous immunoglobulin, bortezomib, and emerging agents such as tocilizumab and imlifidase. This review aims to enhance understanding of the immunological and laboratory aspects of ABO-incompatible transplantation.

Subjects

Author keywords

DesensitizationGraft rejectionHemagglutininsPlasmapheresisTransplantation

Authors and institutions

  • Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, Korea.
  • Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
  • Transplant Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.

ORCID profiles: Kyung-Hwa Shin, Hyun-Ji Lee

Cite

APA

Shin, K. H., & Lee, H. J. (2025). Laboratory approaches in desensitization for ABO-incompatible transplantation. Clinical Transplantation and Research, 39(3), 250-258. https://doi.org/10.4285/ctr.25.0041

Vancouver

Shin KH, Lee HJ. Laboratory approaches in desensitization for ABO-incompatible transplantation. Clinical Transplantation and Research. 2025;39(3):250-258. doi:10.4285/ctr.25.0041

BibTeX
@article{Shin2025,
  author = {Shin, Kyung-Hwa and Lee, Hyun-Ji},
  title = {Laboratory approaches in desensitization for ABO-incompatible transplantation},
  journal = {Clinical Transplantation and Research},
  year = {2025},
  volume = {39},
  number = {3},
  pages = {250--258},
  doi = {10.4285/ctr.25.0041}
}
Start for free →